mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.8 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.8 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |